Log in to save to my catalogue

Response to: ‘Simultaneous inhibition of α4/β7 integrin and tumor necrosis factor-α in concomitant s...

Response to: ‘Simultaneous inhibition of α4/β7 integrin and tumor necrosis factor-α in concomitant s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1992004406

Response to: ‘Simultaneous inhibition of α4/β7 integrin and tumor necrosis factor-α in concomitant spondyloarthritis and inflammatory bowel disease’ by Richard et al

About this item

Full title

Response to: ‘Simultaneous inhibition of α4/β7 integrin and tumor necrosis factor-α in concomitant spondyloarthritis and inflammatory bowel disease’ by Richard et al

Author / Creator

Publisher

England: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2018-12, Vol.77 (12), p.e87-e87

Language

English

Formats

Publication information

Publisher

England: Elsevier Limited

More information

Scope and Contents

Contents

In these cases, anti-TNF therapy has failed to confine gut inflammation. [...]the use of monoclonal antibodies for treatment of extra-articular manifestations may be redundant, unless other EAMs such as psoriasis or uveitis occurred in the disease course. [...]in case of predictable flare of SpA in patients displaying both diseases, the withdrawal...

Alternative Titles

Full title

Response to: ‘Simultaneous inhibition of α4/β7 integrin and tumor necrosis factor-α in concomitant spondyloarthritis and inflammatory bowel disease’ by Richard et al

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1992004406

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1992004406

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2017-212858

How to access this item